Lung cancer patients are at a higher risk for CPA due to the pre-existing compromise of pulmonary function and structure. CPA can mimic or exacerbate symptoms of lung cancer, such as persistent cough, hemoptysis (coughing up blood), and weight loss, making diagnosis and treatment more challenging.
